Summary: Intracerebral microdialysis (MD) was applied in patients with subarachnoid hemorrhage, The regional CBF, the CMR02, and oxygen extraction ratio (OER) were measured with simultaneous positron emission to mography (PET), The aim was to directly correlate alter ations in dialysate levels of energy-related metabolites (lactate, lactate/pyruvate ratio, hypoxanthine) and excit atory amino acids (EAAs) (glutamate and aspartate) to the energy state in the MD probe region as determined by PET, Regional ischemia was defined according to Heiss et al. and Lassen (Heiss et al., 1992; Lassen, 1966) , Whole-brain ischemia was considered present when the OER for the whole brain exceeded the mean whole-brain OER + 2 SD of six reference patients, In general, the presence of whole-brain ischemia and/or regional isch-
emia within the region of the MD probe was associated with increased levels of energy-related metabolites and EAAs retrieved by MD, Increased levels of energy related metabolites and EAAs were only occasionally seen when PET did not show any signs of ischemia or when signs of regional ischemia were found remote from the MD probe region, Thus, the energy-related metabo lites and EAAs may be used as extracellular "markers" of ischemia. PET may be of use in defining critical isch emic regions (tissue at risk) where the MD probe can be inserted for chemical monitoring. Key Words: Cerebral blood flow-Cerebral metabolism-Ischemia-Micro dialysis-Positron emission tomography-Subarachnoid hemorrhage.
sure, repeated computed tomography (CT) scans, and measurements of jugular venous oxygen satu ration and arteriovenous O2 differences.
The intracerebral microdialysis (MD) technique was introduced for long-term monitoring of brain energy metabolism in patients with acute brain in juries in 1992 (Persson and Hillered, 1992) . The method enables the retrieval and analysis of small molecules present in the extracellular fluid (ECF); these include energy-related metabolites (lactate, pyruvate, glucose, adenosine, inosine, and hypo xanthine) and excitatory amino acids (EAAs) (glu tamate and aspartate). The first clinical experience of MD in human brain ischemia was performed in the frontal cortex adjacent to a glioma during lobec tomy; this served as a model of ischemia . The second step was to correlate al" terations in dialysate levels with ischemic/hypoxic events assessed clinically during NIC (Persson and Hillered, 1992) . A 25-fold increase in glutamate and aspartate was found to exist under conditions of energy perturbation, caused by intracranial hyper tension, as indicated by a high lactate/pyruvate ra tio and high levels of hypoxanthine. The chemical ECF alterations largely reflected the overall clinical course. The present study is a further effort to pro vide basic knowledge about the biochemistry of hu man cerebral ischemia by intracerebral MD with the ultimate goal of obtaining a monitoring instrument for the detection of imminent ischemia in routine clinical practice.
The specific aim of the study was to directly cor relate the cortical dialysate levels of energy-related metabolites and EAAs, i. e., the extracellular reflec tion of primarily intracellular metabolic events (Hagberg et al., 1987; Hillered et al. , 1989a, b) , to regional blood flow and energy metabolism, as mea sured by positron emission tomography (PET). Thus, the regional CBF (rCBF), the regional CMR02 (rCMR02) and the regional oxygen extrac tion ratio (rOER) were measured by PET simulta neously with intracerebral MD in patients with sub arachnoid hemorrhage (SAH). The basic question was whether the presence of ischemia in the MD probe region demonstrated by PET was reflected in the dialysate levels of energy-related metabolites and EAAs.
CLINICAL MATERIAL AND METHODS

Patients
Patients with SAH who were referred immediately af ter ictus to the NIC unit were candidates for the study, provided that they had a need of a ventriculostomy for intracranial pressure monitoring and CSF drainage. In formed consent was obtained from the patients them selves or their relatives. The study was approved by the Ethics Committee of the Medical Faculty of U ppsala U ni versity and the University Hospital Radiation Protection Committee. Six patients were investigated, five women and one man, aged 46-70 years (mean age 57 years).
These patients were recruited from a larger group of pa tients with severe SAH studied with long-term intracere bral MD at the NIC unit. The clinical characteristics of the six patients are presented in Table 1 .
Intracerebral MD
An MD probe with a membrane length of 4 mm (CMA/ 10; CMA/Microdialysis, Stockholm, Sweden) was in serted in conjunction with the intraventricular catheter � 2 cm from the midline and 2 cm in front of the coronal suture (Persson and Hillered, 1992 
PET
The PET investigations were performed at the Uppsala University PET Centre (UUPC). The UUPC is situated closely to the NIC unit and intensive care facilities are available at the UUPC; these are of vital importance if patient welfare is not to be compromised. The brain PET camera is equipped with eight rings of 256 detectors, pro ducing 15 axial tomographic slices, which cover 10 cm along the longitudinal axis of the brain (GEMS 2048; Gen eral Electric Medical Systems). In-plane resolution is �6 mm full width at half-maximum, and slice thickness �6.5 mm (Holte et a!., 1989) . Attenuation correction was based on lO-min transmission scans using a rotating 68Ge pin source. Emission images were reconstructed using an 8-mm Hanning filter. 150-labeled gases were adminis tered using a specifically designed cart (PETgas 2000;
General Electric Medical Systems), in which labeled gas from the radiochemistry production unit is mixed with room air or with oxygen-enriched air from the hospital medical gas supply to an adjustable radioactivity concen tration. Patients who were able to cooperate used a mouthpiece and a nonrebreathing valve. In artificially ventilated patients, a small bias flow of labeled gas was fed into the inspiratory hose of the ventilator. Two PET investigations were carried out in each patient, the first within 48 h of hemorrhaging and the second 5-8 days later. Each PET session included measurements of CBF, CMR02, OER, and cerebral blood volume (CBV).
The autoradiographic H2 1sO method was used for mea suring CBF. A bolus of H2 150 was injected into an ante cubital vein at a dose of 15 MBq/kg body wt. Arterial blood was continuously withdrawn via a radial artery catheter and the radioactivity measured. Calculated flow images were created using the auto radiographic method with a predefined distribution volume of 0.95 cm3!cm3 and an integration time of 60 s (Raichle et a!., 1983; Heidenreich et a!., 1992). The time course of the arterial radioactivity concentration was corrected for delay and dispersion by nonlinear fitting to the total count rate for the scanner (Meyer, 1989) .
A bolus administration of CI50 was used for CBV mea surements. CISO was administered during 3-10 breaths, using the system already described. After allowing arte rial and venous CI50 to equilibrate for 2 min, the tomo graph collected 5 I-min frames. Radioactivity concentra tions were measured at 1, 2.5, and 4 min, in whole-blood samples, and blood gas analysis (including CO hemoglobin) was performed on the same samples. Re gional CBV was calculated using the tomographic mea surements, determinations of CI50 in blood, and a con stant correction factor of 0.70 for the difference between peripheral and cerebral hematocrit (Brooks et a!., 1986; Heiss et a!., 1992).
The steady-state 1502 method was used to measure CMR02 and OER. Air mixed with 1502 was administered at a concentration of 4 MBq/min-kg body wt. When a steady-state level of 1502 concentration was attained after 7-8 min, scanning of five to eight I-min frames was initi ated. Arterial blood and plasma were sampled at 1, 2.5, and 4 min for radioactivity measurements and for the de termination of arterial blood O2 content and Peo2. With use of the previously measured CBF, images of OER and CMR02 were created using the summation of data from all the frames acquired (Frackowiak et a!., 1980) . Correc tion for intravascular radioactivity was based on the CBV measurement (Lammertsma and Jones, 1983) .
For the PET measurements, standardized regions of interest (ROIs) were delineated on the H2 150 total radio activity images in two adjacent slices. The ROIs were adjusted with the help of the CBV images to exclude the large venous sinuses. ROIs in adjacent image sections were linked together to "volumes of interest. " To obtain whole-brain values, ROIs of the whole brain excluding the ventricular system and visible regional ischemic le sions were delineated. For regional measurements, each of the areas supplied by the anterior cerebral artery (ACA), middle cerebral artery, and posterior cerebral ar tery, respectively, and the MD probe region were delin eated together with the corresponding contralateral re gions. Visible ischemic lesions on CT or in either PET investigation were also delineated together with the cor responding contralateral regions.
The following definitions of ischemia were used during PET. The occurrence of regional ischemia was assessed by comparing corresponding contralateral regions to min imize the influence of confounding factors in accordance with Heiss et a!. (1992) . Regional ischemia was defined as (a) rOER > 125% and rCMR02? 45% of the correspond ing contralateral region, respectively, suggesting viable tissue with preserved metabolism requiring a blood sup ply (Heiss et a!., 1992); or (b) rCMR02 < 45% of the corresponding contralateral region, indicating a probable infarction (Lassen, 1966; Heiss et aI., 1992) . Whole-brain ischemia was defined as whole-brain OER > 53% (mean OER value + 2 SD of six reference patients who served as normal controls). OER reflects the relation between CBF and CMROz, and an increased OER indicates an insufficient CBF to meet metabolic requirements, i.e., ischemia. By using OER in the definition of whole-brain ischemia, the inevitable problem of confounding effects of variations in the degree of consciousness, hyperventi lation, and sedation, respectively, was overcome.
RESULTS
The whole-brain PET measurements varied con siderably from patient to patient (Table 2 ). The mean whole-brain values for all PET examinations were as follows: CBF 39 ml 100 g-I min -I (range 22-58 ml 100 g-I min-I ), CMR02 128 fLmol 100 ml-I min-I (range 78-2 10 fLmol 100 ml-I min-I ), and OER 49% (range 31-70%). The variability in these parameters appeared, at least partly, to reflect the level of consciousness of the patients, the de gree of sedation, and the degree of hyperventilation (Table 1) . Ischemic levels in the whole brain were found on four occasions in three patients (Table 2) . Regional ischemia was found in several patients, both in the probe region (Table 2 ) and in areas re mote from the probe.
The levels of the chemical substances retrieved by MD are presented in Table 3 in relation to the PET findings. In Fig. 1 , the MD dialysate level (nor mal or increased) is related to the occurrence of ischemia in the probe region on PET. Elevated level of the substances retrieved by MD was generally reflected by ischemia on PET. Chemical alterations were sometimes seen when PET showed no signs of ischemia.
The material was too small to allow detailed sta tistical analysis, but it was found that lactate, lac tate/pyruvate ratio, and glutamate had the highest sensitivity for detecting ischemia, while aspartate and hypoxanthine were less sensitive (Table 4) . The lactate/pyruvate ratio and hypoxanthine had the highest specificity, aspartate intermediate, and lac tate and glutamate the lowest (Table 4) .
Illustrative case: Case 6
A 54-year-old woman, with a short transient loss of consciousness, developed epileptic seizures shortly after admission and was therefore intubated immediately. CT showed SAH and an intracerebral hematoma in the left frontal lobe, suggesting rup- " Reference values based on the mean values ± 2 SD of a reference group of patients. b Whole-brain ischemia denotes OER of the whole brain> 53% (mean OER + 2 SD of the reference patients).
C Regional ischemia denotes either rOER > 125% and CMR02 � 45% of the corresponding contralateral region or rCMR02 < 45% of the corresponding contralateral region (Lassen, 1966; Heiss et aI. , 1992) .
ture of an anterior communicating artery aneurysm. This was confirmed by angiography. A ventricular catheter with an attached MD probe was inserted on day 1. She received propofol sedation and was hyperventilated during PET 1, which took place on the following day. The whole-brain PET values in cluding the probe region were interpreted as ap proximately normal (Table 2 ; Fig. 2 ). Ischemic val ues were seen in the thalamus on both sides (Fig. 2) . The MD values were virtually within the normal range ( Fig. 3; Table 3 ). On day 3 surgery was per formed and the aneurysm clipping provided prob lems. After repeated temporary clipping of the ACAs, the aneurysm was repaired. Postopera tively, the patient deteriorated and CT showed signs of infarction in the territory of the right ACA and in the left caudate nucleus. Follow-up angiog raphy showed signs of moderate diffuse vasospasm and occlusion of the right ACA. In the region cor responding to the right ACA where the MD probe was placed, the PET values indicated manifest in farction (Table 2 ; Fig. 2 ). In the dialysate, all pa rameters except hypoxanthine were increased ( Fig.  3 ; Table 3 ). The MD monitoring results showed that all MD parameters including hypoxanthine had in creased to a maximum on days 3 and 4 and then gradually decreased (Fig. 3) . Therefore, hypoxan thine was in this case considered as elevated in the workup of data.
DISCUSSION
MD is a new method of measuring virtually any low molecular weight substance in the ECF of al most any organ. The MD principle was described by Bito et al. (1966) and Delgado et al. (1972) and a Tentative MD dialysate basal levels (Persson and Hillered, 1992) . has been used in experimental studies of many tis sues including the brain (Bito et aI. , 1966; Delgado et aI. , 1972; see Robinson and Justice, 199 1) . The first reported study in humans was published in 1987 by Lonnroth et aI., who investigated ECF glu cose levels in human adipose tissue. The first expe- riences of MD in the human brain were reported in 1990 (Hillered et aI. , 1990; Meyerson et aI., 1990) . In the present study, PET was used to further val idate the MD technique with the ultimate goal of developing a tool for chemical monitoring of the brain in NIC patients. Interest was focused on en ergy metabolism, and it was thus possible to com pare directly the energy-related substances re trieved by MD with the presence or absence of isch emia on PET. This is, to our knowledge, the first human study where levels of such substances have been directly related to the current hemodynamic and metabolic state of the brain.
One important practical conclusion of this study is that it is indeed possible to perform MD simulta neously with PET in these severely ill patients with out any technical problems or without compromis ing safety. In such a clinical study, it is impossible to obtain a completely homogeneous patient mate rial, and variations in physiological parameters and levels of consciousness are inevitable. The combi nation of MD and PET in NIC patients is a complex and demanding task, which restricts the number of patients. However, the results of this study demon strate a clear agreement between MD and PET in the majority of all measurements.
To overcome interindividual patient variability in the regional analysis of PET results, affected areas were compared with the corresponding contralater al regions according to Heiss and colleagues (1992) . Due to the interindividual variation in all whole brain values, we characterized the regional state of the brain only in terms of ischemia (including in farction) and no ischemia, instead of applying the more detailed description used by Frackowiak et aI. (1980) . The criteria applied in the regional classifi cation of the state of the brain have also been well substantiated and widely accepted previously (Las sen, 1966; Heiss et aI., 1992) . Thus, the results of the regional PET interpretations should be relevant as a basis for evaluating the MD results.
To obtain the most accurate whole-brain assess ments, a high normal upper reference limit (2 SD above the mean of the reference patients) was used. Further, the diagnosis of whole-brain ischemia was based on alterations in OER, which is less affected than CBF and CMR02 by confounding factors such as levels of consciousness, Pco2, and sedation be cause it directly reflects the matching between met abolic demand and oxygen supply.
Lactate and the lactate/pyruvate ratio showed high sensitivity for ischemia, but the specificity of lactate was lower. These findings are in accordance with previous observations that elevated lactate is a rather unspecific finding and may occur in the ab- sence of other signs of ischemia/hypoxia (Persson and Hillered, 1992) . Furthermore, no statistical cor relation was found between dialysate lactate levels and clinical outcome (Persson et at. , 1996) . There are other plausible explanations for the observed lactate elevations than nascent ischemia, such as functional activation and low arterial CO2 content. The ECF lactate/pyruvate ratio seems to reflect ischemia more accurately than lactate and is less dependent on methodological limitations (Persson and Hillered, 1992) and has been found to correlate to clinical outcome (Persson et at. , 1996) .
Hypoxanthine showed a high specificity but a low sensitivity. During energy depletion, the synthesis of ATP stops and the concentration of AMP in creases. AMP is degraded to adenosine, inosine, and hypoxanthine, which accumulates owing to a low xanthine oxidase activity in the brain. It is therefore reasonable to assume that pronounced ischemia, or ischemia of prolonged duration, is re quired to increase the levels of hypoxanthine in the ECF significantly compared with lactate or the lac tate/pyruvate ratio, which seem to react more rap idly to ischemia (Persson et at. , 1996) . This assump tion is in good agreement with the higher specificity and lower sensitivity found for hypoxanthine when J Cereb Blood Flow Me/ab, Vol. 16, No.4, 1996 compared with lactate. The clinical significance of hypoxanthine as a clinical marker of ischemia is underlined by the fact that increased levels corre late with poor clinical outcome (Persson et at. , 1996) .
Excitotoxicity is a well established mechanism for receptor-mediated neuronal damage where the neurons are destroyed by their own EAAs, i.e., glu tamate and aspartate (Olney et at., 1986; Lipton and Rosenberg, 1994) . Little is known about the role of excitotoxicity in the human brain. The sensitivity and specificity of glutamate are difficult to predict because increased ECF levels could be caused by several mechanisms, such as transmitter release, in hibited cellular uptake, unspecific leakage from in jured cells, or diffusion from the blood through the blood-brain barrier, which may be damaged during the ischemic process. We have hypothesized that diffuse leakage from injured brain tissue or through an impaired blood-brain barrier occurs in severe ischemia/infarction (Persson et al., 1996) . The present study showed that glutamate had high sen sitivity and low specificity, i. e., behaved similarly to lactate. Tentatively, the low specificity may be attributed to transmitter release and/or inhibited cellular uptake caused by a low grade of ischemia, which could not be identified by the PET criteria used. Aspartate differed somewhat from glutamate by demonstrating intermediate sensitivity as well as specificity. The reason for this is unclear. However, the ECF levels of both glutamate and aspartate have been shown to correlate with clinical outcome (Persson et aI., 1996) .
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CONCLUDING REMARKS
This study demonstrates an agreement between MD and PET, supporting the hypothesis that the ECF substances retrieved by MD can be used as "markers" of ischemia. Intracerebral MD enables the retrieval of these substances in a clinical setting and may thus serve as an instrument for identifying secondary whole-brain ischemia and focal isch emia, provided that the MD probe is located in the ischemic area. PET may be used to define critical ischemic regions (tissue at risk) in which the MD probe can be inserted.
